Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.
01 1Minakem Beuvry Production
01 1Metyrapone
01 1France
Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.
NDC Package Code : 70219-0001
Start Marketing Date : 2012-07-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
87
PharmaCompass offers a list of Metyrapone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Metyrapone manufacturer or Metyrapone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Metyrapone manufacturer or Metyrapone supplier.
PharmaCompass also assists you with knowing the Metyrapone API Price utilized in the formulation of products. Metyrapone API Price is not always fixed or binding as the Metyrapone Price is obtained through a variety of data sources. The Metyrapone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Metyrapone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Metyrapone, including repackagers and relabelers. The FDA regulates Metyrapone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Metyrapone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Metyrapone supplier is an individual or a company that provides Metyrapone active pharmaceutical ingredient (API) or Metyrapone finished formulations upon request. The Metyrapone suppliers may include Metyrapone API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Metyrapone as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Metyrapone API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Metyrapone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Metyrapone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Metyrapone NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Metyrapone suppliers with NDC on PharmaCompass.
